EMORY DECATUR — History
CCN 110076 | 3-year financial timeline | COVID resilience: 58/100
🛡️ Public data only — no PHI permitted on this instance.
$395M
Latest Revenue (FY2022)
+6.4%
Revenue CAGR (3yr)
-19.5%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $348M | $382M | $395M | +3.2% | +6.4% |
| Operating Expenses | $409M | $480M | $471M | -1.8% | +7.4% |
| Operating Margin | -17.3% | -25.6% | -19.5% | +23.8% | +0.0% |
| Net Income | $-60M | $-98M | $-77M | +21.4% | +0.0% |
| Licensed Beds | 375 | 375 | 393 | +4.8% | +2.4% |
| Total Patient Days | 91,049 | 90,238 | 90,107 | -0.1% | -0.5% |
| Medicare Day % | 16% | 15% | 14% | -11.3% | -8.3% |
| Medicaid Day % | 9% | 9% | 7% | -27.0% | -15.7% |
COVID Impact & Recovery
Resilience Score: 58/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +13.2% ($348M → $395M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+6.4%
This Hospital
+7.6%
State Avg
Latest Margin
-19.5%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $418M | -20.6% |
| FY2024 (proj) | $441M | -21.7% |
| FY2025 (proj) | $464M | -22.9% |